Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2003
03/27/2003WO2002026229A1 Airway mucus secretion inhibitors
03/27/2003WO2002026219A3 Otic microbial combinations for treatment of animals with ruptured tympanic membrane
03/27/2003WO2002019999A3 Compositions for treating sexual dysfunction, containing an no-donor and an antioxidant
03/27/2003WO2002014321A9 Use of stat-6 inhibitors as therapeutic agents
03/27/2003WO2002013802A3 Method of treating estrogen receptor positive carcinoma
03/27/2003WO2002007767A3 Pharmaceutical suspension compositions lacking a polymeric suspending agent
03/27/2003WO2002004006A3 Method for improving the efficacy of artificial insemination of non-human animals
03/27/2003WO2001092218A3 Polyamine analogues as therapeutic and diagnostic agents
03/27/2003WO2001090109A9 Heteroaryldiazabicycloalkanes as nicotinic cholinergic receptor ligands
03/27/2003WO2001079557A3 Gtp-binding protein useful in treatment and detection of cancer
03/27/2003WO2001062954A3 Stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents
03/27/2003US20030061625 Modulation of PDE11A activity
03/27/2003US20030060873 Providing an electrochemical solution comprising metal and bioactive material; contacting electrochemical solution and substrate; forming a bioactive composite structure on substrate using an electrochemical procedure
03/27/2003US20030060645 Polymorphic and other crystalline forms cis-FTC
03/27/2003US20030060640 Cyanation of 1-(4-fluorophenyl)-1,3-dihydroisobenzo-furan for producing antidepressant citalopram
03/27/2003US20030060638 C7 carbamate substituted taxanes
03/27/2003US20030060635 Methods of using bis-indolylquinones
03/27/2003US20030060633 Asymmetric synthesis of kavalactones
03/27/2003US20030060631 An amine substituent at the 7-position of the quinolone-carboxylic acid derivative is produced; bactericides
03/27/2003US20030060629 Pyrazine derivatives as modulators of tyrosine kinases
03/27/2003US20030060627 8-Phenyl-6, 9-dihydro-[1,2,4] triazolo[3,4-i]purin-5-one derivatives
03/27/2003US20030060624 Reacting 2-chloro-4- trifluoromethyl-phenyl)-acetonitrile in the presence of a palladium catalyst and a base to form indene derivative
03/27/2003US20030060623 Having microtubule-stabilizing effects and cytotoxic activity against rapidly proliferating cells, such as, tunior cells or other hyperproliferative cellular disease
03/27/2003US20030060621 Preparation of indolopyrrolocarbazole derivative; obtain chemical intermediates, deblock and recover indolopyrrolocarbazole derivative
03/27/2003US20030060619 Antibody for use in the disgnosis and treatment of kidney, urogenital, and sex disorders
03/27/2003US20030060611 Method and reagent for the inhibition of NOGO gene
03/27/2003US20030060609 For use as antibiotics
03/27/2003US20030060515 Protein tyrosine kinase inhibitors for treating osteoarthritis
03/27/2003US20030060513 First compound selected from muscarinic receptor antagonists, 5-alpha-reductase inhibitors, and alpha-adrenergic receptor antagonists, second compound selected from 5-HT1a receptor agonists and antagonists; urinary disorders
03/27/2003US20030060512 Modulation of inflammation related to columnar epithelia
03/27/2003US20030060511 Method for treatment of ocular hypertension and glaucoma
03/27/2003US20030060510 Administering to the patient a compound capable of reducing glutamate-induced retinal cell migration in a concentration effective to reduce such migration
03/27/2003US20030060509 Omega-6 and omega-3 fatty acids in a variety of forms, such as at least one of highly purified algal oil comprising 70% by weight or more of the desired acid, triglyceride oil combined with phospholipid, protein or dried marine microalgae
03/27/2003US20030060508 Polyunsaturated fatty acid fractions of Nigella sativa L. seeds
03/27/2003US20030060507 Dual inhibitors of cholesteryl ester and wax ester synthesis for sebaceous gland disorders
03/27/2003US20030060506 Bile secretion promoting composition
03/27/2003US20030060505 Administration of a radioprotective alpha, beta unsaturated aryl sulfone compound to a patient prior to anticancer radiotherapy reduces cytotoxic side effects of radiation on normal cells
03/27/2003US20030060502 Method to achieve MHC-class II mediated immunomodulation in a mammal which comprises administering to the mammal at least one statin, or a functionally or structurally equivalent molecule
03/27/2003US20030060501 Facilitating tissue grafts with statins (HMG-COa reductase inhibitors)
03/27/2003US20030060500 Method to achieve MHC-class II mediated immunomodulation in a mammal which comprises administering to the mammal at least one statin, or a functionally or structurally equivalent molecule
03/27/2003US20030060499 Novel therapeutic method
03/27/2003US20030060498 5-arylsulfonyl indoles useful for treating disease
03/27/2003US20030060497 Use of indole Mannich bases in the production of medicaments that are used to treat pain
03/27/2003US20030060493 Kit comprising a pharmaceutical composition containing repinotan or a physiologically acceptable salt of repinotan, and a means for the determination of the concentration of repinotan or its metabolites in body
03/27/2003US20030060492 Nitrosated and nitrosylated H2 receptor antagonist compounds, compositions and methods of use
03/27/2003US20030060491 Bicyclic aromatic compounds
03/27/2003US20030060490 Method for the treatment and prevention of urinary stone disease
03/27/2003US20030060489 Administering an insulin sensitiser (a thiazolidinedione) and an agent used in treatment of cardiac condition associated with diabetes is beta-locker, an ACE inhibitor or diuretic
03/27/2003US20030060488 Drug comprising combination
03/27/2003US20030060487 Useful for treatments for peptide aggregation associated with disease state such as Alzhemimer's diseases
03/27/2003US20030060486 Liquid formulations for the prevention and treatment of mucosal diseases and disorders
03/27/2003US20030060485 (+)-norcisapride
03/27/2003US20030060483 Method of increasing pharmaceutical market
03/27/2003US20030060482 Urease inhibitors
03/27/2003US20030060481 The use of scopolamine salts
03/27/2003US20030060480 Farnesyl protein transferase inhibitor combinations with vinca alkaloids
03/27/2003US20030060479 Compositions and medical device for transdermal delivery of a drug and methods of making and using same
03/27/2003US20030060478 Treatment of dyskinesia
03/27/2003US20030060477 Administering to a patient a betablocker and a cholesterol-lowering agent to treat atherosclerosis, hyperpoproteinemia and hypercholesterolemia
03/27/2003US20030060475 Administering to a patient an effective amount of 1-(2-(4-(3-trifluoromethyl-phenyl)piperazin-1-yl)ethyl)-2,3-dihydro-1H -benzimidazol-2-one or salt, hydrate or solvate for treatment of neurodegnerative diseases
03/27/2003US20030060474 A piperazine compound as antithrombotic agent
03/27/2003US20030060473 Piperazine compounds as inhibitors of MMP or TNF
03/27/2003US20030060470 Ortho, ortho-substituted nitrogen-containing bisaryl compounds, processes for their preparation, their use as medicaments, and pharmaceutical preparation comprising them
03/27/2003US20030060469 Use of substances that act as cascade inhibitors of the raf/mek/erk signal cascade, for producing a medicament to treat dna and rna viruses
03/27/2003US20030060468 Useful for the treatment of disorders involving the central nervous system such as obsessive-compulsive disorder, depression, anxiety, schizophernia, migraine, sleep or eating disorder, obesity, type II diabetes and epilepsy
03/27/2003US20030060467 Substituted pyrazolo(1,5-d)(1,2,4)triazine derivatives, possessing a substitued or nonsubstituted cycloalkyl, phenyl or heteroaryl substituent at 7-position, an alkyl at 4-position, substituted alkoxy at 2-position; antianxiolytic
03/27/2003US20030060466 Such as 6-(4-(4-Fluoro-phenyl)-piperazin-1-yl)-2-methyl-5-nitro-3-(2,2,2-trifluoro -ethyl)-3H-pyrimidin-4-one, which are metabotropic glutamate receptor antagonists useful in treating psychological disorders
03/27/2003US20030060464 Therapeutic 1H-pyrido [ 4, 3-b ] indoles
03/27/2003US20030060463 Preparation of topical regional compositions for the relief of pain
03/27/2003US20030060462 Therapeutic compounds
03/27/2003US20030060461 Cyclic diamine compound with condensed-ring groups
03/27/2003US20030060459 Diamines as modulators of chemokine receptor activity
03/27/2003US20030060458 Indoles and indolines having 5-HT activity
03/27/2003US20030060457 Cellular proteins as targets for the treatment of pathogens resistant to drugs that target pathogen-encoded proteins
03/27/2003US20030060456 Such as 4-(2,3-dihydro-1-benzothien-5-yloxy)-3-((methylamino) methyl)-benzenesulfonamide for use as serotonin re-uptake inhibitors (SSRIs) in treatment of depression, attention deficit hyperactivity disorder, obsessive-compulsive disorder
03/27/2003US20030060455 Treating lung damage from smoke, endometriosis, Behcet's disease, ankylosing spondylitis, cancer, Lyme disease, and/or restenosis following agioplasty with 1-(4-t-butyl-phenyl)-3-(4-(6-morpholin-4-ylmethyl-peperidin-yl)naphthalen-1 -yl)-urea
03/27/2003US20030060454 For treating and preventing skin infections, wounds, bacterial infections, respiratory diseases and disorders, cellulite, cardiovascular disorders, and septic infections
03/27/2003US20030060453 Such as 4-((4-fluorophenyl)hydrazono)-4H-pyrazole- 3,5-diamine for antiproliferative activity, and promoting apoptosis in cells lacking normal regulation of cell cycle and death
03/27/2003US20030060452 N-heterocyclic derivatives as NOS inhibitors
03/27/2003US20030060451 Such as cephalosporin beta-lactam antibiotic (cefditoren pivoxil); drug delivery
03/27/2003US20030060450 Such as 4-(3-chlorophenyl)-6-((4-chlorophenyl)hydroxy(1-methyl-1H-imidazol-5-yl) -methyl)-1-methyl-2(1H)quinoline for treating mammalian tumors via inhibiting farnesyl transferase
03/27/2003US20030060449 Nutraceuticals for treatment of leukemia and solid tumors
03/27/2003US20030060447 Non-aspirating transitional viscoelastics for use in surgery
03/27/2003US20030060445 Comprises oligo-fructose and sialyl-lactose; for increasing the amount of Bifidobacteria and inhibiting the binding of pathogenic bacteria in humans
03/27/2003US20030060441 Administering prodrug component, drug and catalytic component wherein the drug is catalytically released upon contacting the prodrug and catalytic componenets
03/27/2003US20030060440 Oligodeoxynucleotide and its use to induce an immune response
03/27/2003US20030060436 Treatment of parkinson's disease with oligonucleotides
03/27/2003US20030060434 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
03/27/2003US20030060433 Reducing the severity of cancer
03/27/2003US20030060432 Antagonists of the oncogenic activity of the protein mdm2, and use thereof in the treatment of cancers
03/27/2003US20030060431 Base analogues
03/27/2003US20030060430 Site-specific aminoglycoside derivatives and their use in immunodiagnostic assays
03/27/2003US20030060429 Stilbene derivatives and taxanes, vinca alkaloids, alkylating agents, antimetabolites, epidophylloptoxins, platinum compounds, and antibiotics; antitumor agents
03/27/2003US20030060428 Bicyclo (3.2.1)octane in a double ring system having a basic chemical skeletal of a kaurene structure that responds only at elevated plasma glucose concentrations
03/27/2003US20030060427 Dissolving an organic compound having a lactone nucleus in lower alcohol and water; antitumor agents
03/27/2003US20030060426 Formulation for protection against oxidative stress containing benzofuranone derivatives
03/27/2003US20030060425 Immune modulation method using steroid compounds
03/27/2003US20030060424 Bacterial alpha-amylase and/or alpha-glucosidase inhibitors for treating gastrointestinal disorders
03/27/2003US20030060423 Using cyclohexyl or pyran methylenesulfamate derivatives to treat psychological disorders
03/27/2003US20030060422 Tannate compositions and methods of treatment
1 ... 5521 5522 5523 5524 5525 5526 5527 5528 5529 5530 5531 5532 5533 5534 5535 5536 5537 5538 5539 5540 5541 ... 7860